S&P 500   3,977.53 (+0.16%)
DOW   32,432.08 (+0.60%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
S&P 500   3,977.53 (+0.16%)
DOW   32,432.08 (+0.60%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
S&P 500   3,977.53 (+0.16%)
DOW   32,432.08 (+0.60%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
S&P 500   3,977.53 (+0.16%)
DOW   32,432.08 (+0.60%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
Positive News Sentiment  
NYSE:ADCT

ADC Therapeutics - ADCT Earnings Date, Estimates & Call Transcripts

$1.98
+0.06 (+3.13%)
(As of 03/27/2023 04:00 PM ET)
Add
Compare
Today's Range
$1.88
▼
$2.03
50-Day Range
$1.92
▼
$5.45
52-Week Range
$1.85
▼
$16.04
Volume
1.08 million shs
Average Volume
608,806 shs
Market Capitalization
$152.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.17
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

ADCT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ADCT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

ADC Therapeutics Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20232($0.82)$0.10($0.36)
Q2 20232($0.86)($0.84)($0.85)
Q3 20232($0.86)($0.73)($0.80)
Q4 20232($0.89)($0.75)($0.82)
FY 20238($3.43)($2.22)($2.83)

ADCT Earnings Date and Information

ADC Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 8th, 2023 based off prior year's report dates.

ADC Therapeutics Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/8/2023
(Estimated)		        
11/8/2022Q3 2022($0.51)($0.65)($0.14)($0.65)$55.61 million$76.32 million
8/9/2022Q2 2022($0.96)($0.84)+$0.12($0.84)$20.18 million$17.29 million    
5/9/2022Q1 2022($0.76)($0.22)+$0.54($0.22)$29.90 million$46.50 million    
3/3/2022Q4 2021($0.87)($0.45)+$0.42($0.45)$16.40 million$17.01 million    
11/2/20219/30/2021($0.92)($0.93)($0.01)($0.93)$7.74 million$13.15 million    
8/2/20216/30/2021($0.86)($0.96)($0.10)($0.95)$5.70 million$3.76 million    
5/5/20213/31/2021($1.00)($0.46)+$0.54($0.67)  
3/17/202112/31/2020($0.68)($0.73)($0.05)($0.73)  
11/12/2020Q3 2020($0.77)($0.29)+$0.48($0.29)
8/18/2020Q2 2020($0.96)($0.71)+$0.25$0.59












ADC Therapeutics Earnings - Frequently Asked Questions

When is ADC Therapeutics's earnings date?

ADC Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 8th, 2023 based off last year's report dates. Learn more on ADCT's earnings history.

How much revenue does ADC Therapeutics generate each year?

ADC Therapeutics (NYSE:ADCT) has a recorded annual revenue of $209.91 million.

How much profit does ADC Therapeutics generate each year?

ADC Therapeutics (NYSE:ADCT) has a recorded net income of -$155.80 million. ADCT has generated -$2.01 earnings per share over the last four quarters.

What is ADC Therapeutics's EPS forecast for next year?

ADC Therapeutics's earnings are expected to decrease from ($2.31) per share to ($2.84) per share in the next year.

More Earnings Resources from MarketBeat

Earnings Tools:
Earnings By Country:
Latest Articles:
Upcoming Earnings:
This page (NYSE:ADCT) was last updated on 3/27/2023 by MarketBeat.com Staff